Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

NIAGEN BIOSCIENCE, INC. (NAGE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-18.

Discontinued › Notes › Leases

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2020-05-18

  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was -$2.00K.
  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $62.00K.
  • NIAGEN BIOSCIENCE, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2018 was $0.00.
Period endRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month
2020-03-31$0.00
10-Q · filed 2020-05-18
-$2.00K
derived: sum of 2 quarters · filed 2020-05-18
-$2.00K
derived: sum of 3 quarters · filed 2020-05-18
-$2.00K
derived: sum of 4 quarters · filed 2020-05-18
2019-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$2.00K
derived: sum of 2 quarters · filed 2020-03-10
-$2.00K
derived: sum of 3 quarters · filed 2020-03-10
$62.00K
10-K · filed 2020-03-10
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$0.00
derived: sum of 2 quarters · filed 2019-11-12
$64.00K
10-Q · filed 2019-11-12
$64.00K
derived: sum of 4 quarters · filed 2020-05-18
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$64.00K
10-Q · filed 2019-08-07
$64.00K
derived: sum of 3 quarters · filed 2020-05-18
$64.00K
derived: sum of 4 quarters · filed 2020-05-18
2019-03-31$64.00K
10-Q · filed 2020-05-18
$64.00K
derived: sum of 2 quarters · filed 2020-05-18
$64.00K
derived: sum of 3 quarters · filed 2020-05-18
$64.00K
derived: sum of 4 quarters · filed 2020-05-18
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$0.00
derived: sum of 2 quarters · filed 2020-03-10
$0.00
derived: sum of 3 quarters · filed 2020-03-10
$0.00
10-K · filed 2020-03-10
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$0.00
derived: sum of 2 quarters · filed 2019-11-12
$0.00
10-Q · filed 2019-11-12
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$0.00
10-Q · filed 2019-08-07
2018-03-31$0.00
10-Q · filed 2019-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87